4//SEC Filing
Parini Michael 4
Accession 0001209191-21-012347
CIK 0000875320other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:18 PM ET
Size
12.1 KB
Accession
0001209191-21-012347
Insider Transaction Report
Form 4
Parini Michael
EVP & CLO
Transactions
- Tax Payment
Common Stock
2021-02-17$211.75/sh−6,240$1,321,320→ 44,106 total - Sale
Common Stock
2021-02-18$210.08/sh−1,007$211,551→ 43,099 total - Sale
Common Stock
2021-02-18$211.83/sh−4,666$988,399→ 38,433 total - Sale
Common Stock
2021-02-18$212.56/sh−1,952$414,917→ 36,481 total - Sale
Common Stock
2021-02-18$213.45/sh−200$42,690→ 36,281 total
Footnotes (6)
- [F1]Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $210.08 (range $209.60 to $210.54).
- [F3]Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $211.83 (range $211.25 to $212.24).
- [F5]Open market sales reported on this line occurred at a weighted average price of $212.56 (range $212.25 to $212.95).
- [F6]Open market sales reported on this line occurred at a weighted average price of $213.45 (range $213.30 to $213.68).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001661567
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:18 PM ET
- Size
- 12.1 KB